Development and Validation of a Novel Diagnostic Test for Human Brucellosis Using a Glyco-engineered Antigen Coupled to Magnetic Beads

PLoS Neglected Tropical Diseases

Volumn 7, Issue 2, 2013, Pages

  Ciocchini, Andrés E ^a   Rey Serantes, Diego A ^a   Melli, Luciano J ^a   Iwashkiw, Jeremy A ^b   Deodato, Bettina ^c   Wallach, Jorge ^c   Feldman, Mario F ^b   Ugalde, Juan E ^a   Comerci, Diego J ^a,d  

^a INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

^b UNIVERSITY OF ALBERTA   (Canada)

^c HOSPITAL F J MUÑIZ   (Argentina)

^d CENTRO ATÓMICO EZEIZA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; RECOMBINANT O 9 POLYSACCHARIDE PROTEIN CONJUGATE; UNCLASSIFIED DRUG;

ARTICLE; BRUCELLOSIS; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VAIDATION PROCESS; WESTERN BLOTTING; YERSINIA ENTEROCOLITICA;

EID: 84874762733     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002048     Document Type: Article

References (25)

1. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV, (2006) The new global map of human brucellosis. Lancet Infect Dis 6: 91-99.
2. Franco MP, Mulder M, Gilman RH, Smits HL, (2007) Human brucellosis. Lancet Infect Dis 7: 775-786.
3. Young EJ, (1995) An overview of human brucellosis. Clin Infect Dis 21: 283-289 quiz 290.
4. Al Dahouk S, Nockler K, (2011) Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther 9: 833-845.
5. Araj GF, (2010) Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents 36 Suppl 1: S12-17.
6. Iwashkiw JA, Fentabil MA, Faridmoayer A, Mills DC, Peppler M, et al. (2012) Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis. Microb Cell Fact 11: 13.
7. Feldman MF, Wacker M, Hernandez M, Hitchen PG, Marolda CL, et al. (2005) Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc Natl Acad Sci U S A 102: 3016-3021.
8. Lucero NE, Foglia L, Ayala SM, Gall D, Nielsen K, (1999) Competitive enzyme immunoassay for diagnosis of human brucellosis. J Clin Microbiol 37: 3245-3248.
9. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227: 680-685.
10. Burnett WN, (1981) "Western Blotting": electrophoretic transfer of proteins from sodium dodecyl sulphate-polyacrylamide gels to unmodified nitrocelulose and radiographic detection with antibody and radioiodinated protein A. Ann Biochem 112: 195-203.
11. Nielsen KH, Kelly L, Gall D, Nicoletti P, Kelly W, (1995) Improved competitive enzyme immunoassay for the diagnosis of bovine brucellosis. Vet Immunol Immunopathol 46: 285-291.
12. Greiner M, Pfeiffer D, Smith RD, (2000) Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 45: 23-41.
13. Swets JA, (1988) Measuring the accuracy of diagnostic systems. Science 240: 1285-1293.
14. Noviello S, Gallo R, Kelly M, Limberger RJ, DeAngelis K, et al. (2004) Laboratory-acquired brucellosis. Emerg Infect Dis 10: 1848-1850.
15. Robichaud S, Libman M, Behr M, Rubin E, (2004) Prevention of laboratory-acquired brucellosis. Clin Infect Dis 38: e119-122.
16. Wallach JC, Ferrero MC, Victoria Delpino M, Fossati CA, Baldi PC, (2008) Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina. Clin Microbiol Infect 14: 805-807.
17. Yagupsky P, Baron EJ, (2005) Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis 11: 1180-1185.
18. Bundle DR, Perry MB, (1985) Structure and serology of the Brucella abortus O-antigen. Biochem Soc Trans 13: 980-982.
19. Caroff M, Bundle DR, Perry MB, (1984) Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9. Eur J Biochem 139: 195-200.
20. Meikle PJ, Perry MB, Cherwonogrodzky JW, Bundle DR, (1989) Fine structure of A and M antigens from Brucella biovars. Infect Immun 57: 2820-2828.
21. Al Dahouk S, Tomaso H, Nockler K, Neubauer H, Frangoulidis D, (2003) Laboratory-based diagnosis of brucellosis-a review of the literature. Part II: serological tests for brucellosis. Clin Lab 49: 577-589.
22. Diaz R, Casanova A, Ariza J, Moriyon I, (2011) The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease. PLoS Negl Trop Dis 5: e950.
23. Smits HL, Abdoel TH, Solera J, Clavijo E, Diaz R, (2003) Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis. Clin Diagn Lab Immunol 10: 1141-1146.
24. Girosi F, Olmsted SS, Keeler E, Hay Burgess DC, Lim YW, et al. (2006) Developing and interpreting models to improve diagnostics in developing countries. Nature 444 Suppl 1: 3-8.
25. Hay Burgess DC, Wasserman J, Dahl CA, (2006) Global health diagnostics. Nature 444 Suppl 1: 1-2.